Get started
Author

László Szilberhorn

Observed names: L Szilberhorn, L. Szilberhorn, Laszlo Szilberhorn, Szilberhorn, László
ORCID: 0000-0003-2556-397X
Observed ORCID: 0000-0003-2556-397X
OpenAlex ID: A5009384045
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
2022 · Rositsa Koleva-Kolarova, James Buchanan, et al. · Applied Health Economics and Health Policy · 70
PDF
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
2022 · Heleen Vellekoop, Matthijs Versteegh, et al. · Value in Health · 49
PDF
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
2021 · Heleen Vellekoop, Simone Huygens, et al. · PharmacoEconomics · 48
PDF
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib
2022 · Simone Huygens, Heleen Vellekoop, et al. · Value in Health · 16
PDF
Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary
2022 · Balázs Nagy, László Szilberhorn, et al. · Value in Health Regional Issues · 12
PDF
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation
2023 · Rositsa Koleva-Kolarova, László Szilberhorn, et al. · Personalized Medicine · 11
PDF
Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
2023 · László Lorenzovici, László Szilberhorn, et al. · BioDrugs · 9
PDF
Cost-Effectiveness of Second-generation Direct-acting Antiviral Agents in Chronic HCV Infection: A Systematic Literature Review
2018 · László Szilberhorn, Zoltán Kaló, et al. · Antiviral Therapy · 9
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK
2023 · Rositsa Koleva-Kolarova, Heleen Vellekoop, et al. · Personalized Medicine · 8
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young
2023 · Gábor Kovács, Dávid Nagy, et al. · Personalized Medicine · 8
Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography: Comparing Hungarian Screening Protocols with the US NLST
2024 · Tanya Rajabi, László Szilberhorn, et al. · Cancers · 6
PDF
Budget Impact and Transferability of Cost–effectiveness of DPYD Testing in Metastatic Breast Cancer in Three Health Systems
2023 · Rositsa Koleva-Kolarova, Heleen Vellekoop, et al. · Personalized Medicine · 6
Cost–effectiveness of Alternative NTRK Testing Strategies in Cancer Patients Followed by Histology-Independent Therapy with Entrectinib: an Analysis of Three European Countries
2023 · Heleen Vellekoop, Simone Huygens, et al. · Personalized Medicine · 6
Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
2017 · Tomas Tesar, Laszlo Szilberhorn, et al. · Frontiers in Pharmacology · 5
PDF
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
2023 · László Szilberhorn, Tamás Zelei, et al. · Personalized Medicine · 3
Lessons Learned from the Application of the HEcoPerMed Guidance to Three Modeling Case Studies
2023 · Balázs Nagy, Tamás Zelei, et al. · Personalized Medicine · 3
PDF
Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary
2019 · László Szilberhorn, László Kőrösi, et al. · Primary care diabetes · 3
A kis sugárdózisú komputertomográfia szerepe a tüdőrákszűrésben
2022 · Tamás Ágh, László Szilberhorn, et al. · Orvosi Hetilap · 2
PDF
Ppm6 Early Phase Economic Evaluation of New Generation Sequence Diagnostics in Multiple Myeloma
2020 · Z. Kalo, I. Valyi-Nagy, et al. · Value in Health · 2
Pin64 Cost of Hepatitis C Virus Eradication: Economic Model Concept
2019 · L. Szilberhorn, Z. Kalo, et al. · Value in Health · 1
PDF
Prm131 - Hepatitis C Virus Elimination and Eradication Models: a Systematic Literature Review
2018 · L Szilberhorn, T Ágh, et al. · Value in Health · 1
Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection: A Systematic Literature Review
2017 · L Szilberhorn, T Ágh, et al. · Value in Health · 1
Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States
2015 · T Ágh, M Pawaskar, et al. · Value in Health · 1
PDF
Cost-Effectiveness Analysis of Ceftazidime/Avibactam Versus Polymyxin E in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: Literature Review
2023 · Ahmad Fasseeh, Amany Salem, et al. · The Egyptian Journal of Hospital Medicine
PDF
EE325 Cost-Effectiveness of Lung Cancer Screening With Low Dose Computed Tomography in Hungary
2022 · B Nagy, L Szilberhorn, et al. · Value in Health
Works count: 32
Citation count: 280
H-index: 8
I10-index: 6
Year
Topic
Type